Provider review
OrderlyMeds Review: The Cheapest Headline Here, and It Says Why
$74 a month is the lowest advertised figure on this site, and it is a two-month starter rate for new customers only. What makes OrderlyMeds worth reading is where it says so: $149 a month thereafter is printed on the same card, not in a footnote at the bottom of the page. The price is not the story here. The disclosure is.
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
The money verdict
The cheapest advertised compounded semaglutide we have priced, on a two-month starter — and the rare company that prints the $149 renewal on the same card rather than in a footnote.
Worth it if
- You want the lowest entry price for compounded semaglutide and will still be there at month three
- You would rather a company told you the renewal rate up front than buried it
- You want the option of branded Wegovy or Zepbound from the same provider
Look elsewhere if
- You are comparing on advertised prices — the starter rate is not what you will pay
- You want the compounding pharmacy named, which this company does not do
- An open FDA warning letter about how a product was labeled would stop you buying
$149/mo
No exclusions disclosed
Monthly (12×/yr)
At a glance
$74/mo
Advertised
$149/mo
Walk-away
$1,788
Year at this price
The same Semaglutide price, three ways
The short bar is the number OrderlyMeds leads with. It lasts one cycle.
Advertised
first cycle only
$74
Walk-away
every cycle after
$149
Ready to check OrderlyMeds’s current price?
Prices may change.
Best for: You want the lowest entry price for compounded semaglutide and will still be there at month three Skip it if: You are comparing on advertised prices — the starter rate is not what you will pay
Pricing, per compound
Everything OrderlyMeds sells, cheapest year first. “Advertised” is the price it leads with; “Walk-away” is what you pay if you stop after one cycle.
| Provider | Advertised | Walk-away | Year at this price |
|---|---|---|---|
Semaglutide — compounded injection The card reads “Get started for as little as $74 a month*” and, directly beneath it, “$149/mo thereafter”. The /pricing page names the term: a “2 month starter program”, $149 for two months, marked “Special offer pricing only available to new customers”. So a first year is about $1,639 and a full year at the standing rate is $1,788. The row is filed at the renewal because that is what a reader pays from month three. | $74.00/mo | $149.00/mo | $1,788.00 $149.00 × 12 months |
Tirzepatide — compounded injection Same structure: “as little as $149 a month*” with “$299/mo thereafter” on the card, and $299 for two months on /pricing. A first year is about $3,289; a standing year is $3,588. | $149.00/mo | $299.00/mo | $3,588.00 $299.00 × 12 months |
Tirzepatide — Zepbound pen, brand Branded Zepbound at $1,498 a month, flat. $17,976 a year. Both brand rows are close to list and are priced without a promotion attached. | $1,498.00/mo | $1,498.00/mo | $17,976.00 $1,498.00 × 12 months |
Semaglutide — Wegovy pen, brand Branded Wegovy at $1,839 a month, listed flat with no starter rate and no “from”. $22,068 a year, and roughly twelve times the standing compounded price at the same company. | $1,839.00/mo | $1,839.00/mo | $22,068.00 $1,839.00 × 12 months |
The year at this dose — 12 payments, or 13 where a seller bills every four weeks. Several charge more as you move to a higher dose; where they publish that, the row says so.
Every figure above was read on orderlymeds.com, one product at a time. Check the current price before you buy.
See OrderlyMeds’s pricesHow this compares
On our compounded tirzepatide board, OrderlyMeds is $299 and the cheapest we have priced is Embody — weekly injection at $129.
See every compounded tirzepatide price we have checked →On our compounded semaglutide board, OrderlyMeds is $149 and the cheapest we have priced is Embody — weekly injection at $79.
See every compounded semaglutide price we have checked →On our zepbound board, OrderlyMeds is $1,498 and the cheapest we have priced is LillyDirect — tirzepatide, 2.5 mg at $299.
See every zepbound price we have checked →
Pros and cons
Pros
- The renewal rate is printed on the same card as the starter rate — “$149/mo thereafter” sits directly under “as little as $74 a month”.
- The starter term is stated plainly as a two-month program on the pricing page, with the two-month total shown, so the offer can be checked rather than inferred.
- The promotion is labeled as new-customer-only rather than presented as a standing price.
- Both compounded and FDA-approved branded options are priced openly on one page, so the comparison is available before signing up.
- The operating company is named in the footer — OrderlyMeds LLC — which a surprising number of its competitors do not do.
- Billing is monthly with no prepay term, so there is nothing to be locked into.
Cons
- The advertised figure still doubles at month three, from $74 to $149 on semaglutide and from $149 to $299 on tirzepatide.
- No compounding pharmacy is named anywhere, so a reader cannot check who makes the medication or under what license.
- An open FDA warning letter (728291, June 2026) found the site's product photos carried OrderlyMeds' own logo on the label, implying it compounds drugs it does not compound.
- The same letter found the site described its pharmacy as “FDA-licensed”.
- Branded Wegovy at $1,839 and Zepbound at $1,498 a month are near list price, with none of the manufacturer-channel savings some competitors pass through.
- The weight-loss figures on the homepage are the company's own customer data, not trial results, and are marked with an asterisk rather than explained in place.
How we verified this
What we checked
- Every price read off orderlymeds.com — 4 products, checked one at a time
- The billing cycle taken from the company's own terms, not assumed from the price
- States, inclusions and cancellation terms read on the company's own pages
- Screened against the FDA's live warning-letter index
What to double-check before you buy
- Prices may change. Confirm before you buy.
Key terms
Show definitions
- Walk-away price
- What one cycle costs at the ongoing rate with no commitment — what you actually pay if you stop after month one.
- Year at this price
- The walk-away price multiplied by however many times a year it's actually billed. ⚠ It's the year at THIS dose — several sellers charge more as you move up, and most don't publish the ladder.
- Compounded
- Made to order by a pharmacy from raw ingredients, rather than dispensed as an FDA-approved, mass-manufactured product.
Bottom line
Budget $149 a month for compounded semaglutide — $1,788 a year — and treat $74 as the first two months only. That is a fair standing price, and OrderlyMeds is one of the few companies here that tells you what it becomes before you buy. Ask which pharmacy compounds it, because the site does not say and FDA has already told this company off for implying it does the compounding itself.
Visit OrderlyMedsFrequently asked questions
Is OrderlyMeds really $74 a month?
For two months, if you are a new customer. The card says “Get started for as little as $74 a month*” and immediately beneath it “$149/mo thereafter”, and the pricing page describes it as a two-month starter program at $149 for the two months. So the standing price for compounded semaglutide is $149 a month, or $1,788 a year.
How does that compare with the rest of the market?
$149 a month at the standing rate is toward the cheap end of the compounded semaglutide market rather than the bottom of it — the $74 headline is what makes it look like an outlier. Compounded tirzepatide runs $299 a month after its own two-month starter.
Does OrderlyMeds have an FDA warning letter?
Yes — letter 728291, issued 8 June 2026 and still open. It is worth reading because it is not the usual complaint. FDA quoted no claims comparing the compounded product to Wegovy or Ozempic. Instead it found that product photos carried OrderlyMeds' own logo on the label, implying the company compounds drugs it does not compound, and that the site called its pharmacy “FDA-licensed”, which no compounding pharmacy is. There is no product-quality or contamination finding, and a warning letter is a disclosure rather than a disqualification.
Who compounds the medication?
The site does not say, and that gap is what its FDA letter turns on. A reader cannot check the pharmacy, its state license, or its inspection record, because none is named. Worth asking before you buy.
Sources
Every price above was checked against OrderlyMeds’s own pricing page — never a third-party aggregator:
Show every source link
- OrderlyMeds — official site
Where we read every figure on this page
- FDA warning letter
June 2026
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.